Catalyst Wire Dossier Catalyst Wire Dossier

Benmelstobart

Drug timelines are a Plus or Pro feature.

22 regulatory and trial events tracked for Benmelstobart, covering 2024-07-31 to 2026-04-20. Get the full timeline:

Most recent: Clinical Trial Update: Benmelstobart Plus Anlotinib, Chemotherapy and Thoracic Radiation for Limited-Stage Small Cell Lung Cancer [Phase 2]

See pricing